KK
KLP Kapitalforvaltning Portfolio holdings
AUM $23.2B
This Quarter Return
+14.13%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$23.2B
AUM Growth
+$2.77B
(+14%)
Cap. Flow
+$677M
Cap. Flow
% of AUM
2.92%
Top 10 Holdings %
Top 10 Hldgs %
31.18%
Holding
2,276
New
24
Increased
1,240
Reduced
353
Closed
88
Top Buys
| 1 |
Microsoft
MSFT
|
+$44.7M |
| 2 |
Capital One
COF
|
+$44.4M |
| 3 |
Amazon
AMZN
|
+$35M |
| 4 |
NVIDIA
NVDA
|
+$32.4M |
| 5 |
Meta Platforms (Facebook)
META
|
+$20.1M |
Top Sells
| 1 |
HES
Hess
HES
|
+$54.3M |
| 2 |
DFS
Discover Financial Services
DFS
|
+$28.4M |
| 3 |
CMS Energy
CMS
|
+$12.9M |
| 4 |
NetApp
NTAP
|
+$12.7M |
| 5 |
Hologic
HOLX
|
+$12.7M |
Sector Composition
| 1 | Technology | 33.47% |
| 2 | Financials | 14% |
| 3 | Consumer Discretionary | 10.47% |
| 4 | Healthcare | 10.11% |
| 5 | Communication Services | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1601
NCR Voyix
VYX
$1.77B
| $301K | ﹤0.01% |
25,700
-4,100
| -14% | -$48.1K |
|
1602
Amneal Pharmaceuticals
AMRX
$3.06B
| $300K | ﹤0.01% |
37,100
+9,400
| +34% | +$76K |
|
1603
Ibotta
IBTA
$764M
| $300K | ﹤0.01% |
8,200
+6,800
| +486% | +$249K |
|
1604
Beam Therapeutics
BEAM
$2.32B
| $298K | ﹤0.01% |
17,500
-2,000
| -10% | -$34K |
|
1605
La-Z-Boy
LZB
$1.4B
| $297K | ﹤0.01% |
8,000
| – | – |
|
1606
Alaska Air
ALK
$6.64B
| $297K | ﹤0.01% |
6,000
-700
| -10% | -$34.6K |
|
1607
Plug Power
PLUG
$1.94B
| $297K | ﹤0.01% |
199,200
+49,200
| +33% | +$73.3K |
|
|
NVEE
1608
DELISTED
NV5 Global
NVEE
| $296K | ﹤0.01% |
12,800
| – | – |
|
1609
Certara
CERT
$1.86B
| $295K | ﹤0.01% |
25,200
-6,200
| -20% | -$72.5K |
|
1610
Limbach Holdings
LMB
$1.15B
| $294K | ﹤0.01% |
2,100
+300
| +17% | +$42K |
|
1611
Adaptive Biotechnologies
ADPT
$1.97B
| $291K | ﹤0.01% |
25,000
+7,500
| +43% | +$87.4K |
|
1612
Global Net Lease
GNL
$1.79B
| $291K | ﹤0.01% |
38,570
| – | – |
|
1613
Wolverine World Wide
WWW
$2.47B
| $289K | ﹤0.01% |
16,000
| – | – |
|
1614
Reynolds Consumer Products
REYN
$4.85B
| $289K | ﹤0.01% |
13,500
| – | – |
|
1615
Travere Therapeutics
TVTX
$2.03B
| $289K | ﹤0.01% |
19,500
+4,500
| +30% | +$66.6K |
|
1616
Omnicell
OMCL
$1.48B
| $288K | ﹤0.01% |
9,800
| – | – |
|
1617
IDT Corp
IDT
$1.67B
| $287K | ﹤0.01% |
4,200
-1,200
| -22% | -$82K |
|
1618
Dr. Reddy's Laboratories
RDY
$12.3B
| $286K | ﹤0.01% |
19,000
+13,000
| +217% | +$195K |
|
1619
Vita Coco
COCO
$2.27B
| $285K | ﹤0.01% |
7,900
-2,900
| -27% | -$105K |
|
1620
Blue Bird Corp
BLBD
$1.84B
| $285K | ﹤0.01% |
6,600
| – | – |
|
1621
Teladoc Health
TDOC
$1.39B
| $285K | ﹤0.01% |
32,700
| – | – |
|
1622
Amicus Therapeutics
FOLD
$2.47B
| $284K | ﹤0.01% |
49,600
+7,400
| +18% | +$42.4K |
|
1623
Under Armour
UAA
$2.08B
| $284K | ﹤0.01% |
41,600
| – | – |
|
|
STR
1624
DELISTED
Sitio Royalties
STR
| $282K | ﹤0.01% |
15,363
-1,900
| -11% | -$34.9K |
|
1625
Hilltop Holdings
HTH
$2.13B
| $282K | ﹤0.01% |
9,300
-1,100
| -11% | -$33.4K |
|